Inovio Pharmaceuticals
INO
#9328
Rank
โ‚น5.45 B
Marketcap
โ‚น148.61
Share price
1.16%
Change (1 day)
-82.56%
Change (1 year)

Revenue for Inovio Pharmaceuticals (INO)

Revenue in 2024 (TTM): โ‚น18.43 Million

According to Inovio Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น18.59 Million. a decrease over the revenue in the year 2023 that were of โ‚น69.26 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inovio Pharmaceuticals from 1999 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น18.68 M-73.03%
2023 โ‚น69.26 M-91.84%
2022 โ‚น0.84 B542.86%
2021 โ‚น0.13 B-75.63%
2020 โ‚น0.54 B84.84%
2019 โ‚น0.29 B-86.24%
2018 โ‚น2.13 B-20.94%
2017 โ‚น2.69 B12.16%
2016 โ‚น2.40 B-10.86%
2015 โ‚น2.69 B306.84%
2014 โ‚น0.66 B-20.35%
2013 โ‚น0.83 B268.95%
2012 โ‚น0.22 B-56.48%
2011 โ‚น0.51 B88.19%
2010 โ‚น0.27 B-34.93%
2009 โ‚น0.42 B319.72%
2008 โ‚น0.10 B-46.56%
2007 โ‚น0.18 B22.83%
2006 โ‚น0.15 B-37.57%
2005 โ‚น0.24 B386.75%
2004 โ‚น50.54 M1278.56%
2003 โ‚น3.66 M-59.66%
2002 โ‚น9.08 M
2000 โ‚น0.25 B-32.09%
1999 โ‚น0.38 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น5.434 T 29,218,842.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.586 T 40,789,131.98%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.21 B 1,048.07%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.417 T 23,752,173.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น5.480 T 29,467,744.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.431 T 18,452,000.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น2.455 T 13,204,128.59%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น53.96 M 190.16%๐Ÿ‡บ๐Ÿ‡ธ USA